Growth Metrics

Moderna (MRNA) Interest & Investment Income (2018 - 2025)

Historic Interest & Investment Income for Moderna (MRNA) over the last 8 years, with Q3 2025 value amounting to $73.0 million.

  • Moderna's Interest & Investment Income fell 2912.62% to $73.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $335.0 million, marking a year-over-year decrease of 2334.1%. This contributed to the annual value of $425.0 million for FY2024, which is 95.01% up from last year.
  • According to the latest figures from Q3 2025, Moderna's Interest & Investment Income is $73.0 million, which was down 2912.62% from $81.0 million recorded in Q2 2025.
  • In the past 5 years, Moderna's Interest & Investment Income registered a high of $120.0 million during Q1 2024, and its lowest value of $3.0 million during Q2 2021.
  • For the 5-year period, Moderna's Interest & Investment Income averaged around $68.8 million, with its median value being $87.0 million (2022).
  • As far as peak fluctuations go, Moderna's Interest & Investment Income plummeted by 5714.29% in 2021, and later surged by 135000.0% in 2022.
  • Moderna's Interest & Investment Income (Quarter) stood at $7.0 million in 2021, then surged by 1142.86% to $87.0 million in 2022, then grew by 18.39% to $103.0 million in 2023, then decreased by 11.65% to $91.0 million in 2024, then fell by 19.78% to $73.0 million in 2025.
  • Its Interest & Investment Income stands at $73.0 million for Q3 2025, versus $81.0 million for Q2 2025 and $90.0 million for Q1 2025.